Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering
- PMID: 20056174
- DOI: 10.1016/j.actbio.2009.12.054
Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering
Abstract
Novel multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds exhibiting potential for drug delivery were developed for bone tissue engineering. 45S5 Bioglass-based glass-ceramic scaffolds of high interconnected porosity produced using the foam-replication technique were coated with biodegradable microspheres (size<2 microm) made from poly(3-hydroxybutyrate), P(3HB), produced using Bacillus cereus SPV. A solid-in-oil-in-water emulsion solvent extraction/evaporation technique was used to produce these P(3HB) microspheres. A simple slurry-dipping method, using a 1 wt.% suspension of P(3HB) microspheres in water, dispersed by an ultrasonic bath, was used to coat the scaffold, producing a uniform microsphere coating throughout the three-dimensional scaffold structure. Compressive strength tests confirmed that the microsphere coating slightly enhanced the scaffold mechanical strength. It was also confirmed that the microsphere coating did not inhibit the bioactivity of the scaffold when immersed in simulated body fluid (SBF) for up to 4 weeks. The hydroxyapatite (HA) growth rate on P(3HB) microsphere-coated 45S5 Bioglass composite scaffolds was very similar to that on the uncoated control sample, qualitatively indicating similar bioactivity. However, the surface topography of the HA surface layer was affected as shown by results obtained from white light interferometry. The roughness of the surface was much higher for the P(3HB) microsphere-coated scaffolds than for the uncoated samples, after 7 days in SBF. This feature would facilitate cell attachment and proliferation. Finally, gentamycin was successfully encapsulated into the P(3HB) microspheres to demonstrate the drug delivery capability of the scaffolds. Gentamycin release kinetics was determined using liquid chromatography-mass spectrometry. The release of the drug from the coated composite scaffolds was slow and controlled when compared to the observed fast and relatively uncontrolled drug release from the bone scaffold (without microsphere coating). Thus, this unique multifunctional bioactive composite scaffold has the potential to enhance cell attachment and to provide controlled delivery of relevant drugs for bone tissue engineering.
Copyright 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Preparation and characterization of PHBV microsphere/45S5 bioactive glass composite scaffolds with vancomycin releasing function.Mater Sci Eng C Mater Biol Appl. 2014 Aug 1;41:320-8. doi: 10.1016/j.msec.2014.04.052. Epub 2014 Apr 29. Mater Sci Eng C Mater Biol Appl. 2014. PMID: 24907766
-
In vitro biocompatibility of 45S5 Bioglass-derived glass-ceramic scaffolds coated with poly(3-hydroxybutyrate).J Tissue Eng Regen Med. 2009 Feb;3(2):139-48. doi: 10.1002/term.150. J Tissue Eng Regen Med. 2009. PMID: 19170250
-
Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications.Biomaterials. 2010 Apr;31(10):2806-15. doi: 10.1016/j.biomaterials.2009.12.045. Epub 2010 Jan 4. Biomaterials. 2010. PMID: 20045554
-
Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering.Biomaterials. 2006 Jun;27(18):3413-31. doi: 10.1016/j.biomaterials.2006.01.039. Epub 2006 Feb 28. Biomaterials. 2006. PMID: 16504284 Review.
-
Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future.J Biomed Mater Res A. 2011 Jun 15;97(4):514-35. doi: 10.1002/jbm.a.33072. Epub 2011 Apr 4. J Biomed Mater Res A. 2011. PMID: 21465645 Review.
Cited by
-
Effect of heat treatment on the properties of SiO2-CaO-MgO-P 2O 5 bioactive glasses.J Mater Sci Mater Med. 2012 Sep;23(9):2101-8. doi: 10.1007/s10856-012-4699-y. Epub 2012 Jun 15. J Mater Sci Mater Med. 2012. PMID: 22699712
-
Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.Int J Mol Sci. 2010 Sep 15;11(9):3298-322. doi: 10.3390/ijms11093298. Int J Mol Sci. 2010. PMID: 20957095 Free PMC article. Review.
-
Biomaterials advances in patches for congenital heart defect repair.J Cardiovasc Transl Res. 2011 Oct;4(5):646-54. doi: 10.1007/s12265-011-9289-8. Epub 2011 Jun 7. J Cardiovasc Transl Res. 2011. PMID: 21647794 Review.
-
Tetracycline-encapsulated P(3HB) microsphere-coated 45S5 Bioglass(®)-based scaffolds for bone tissue engineering.J Mater Sci Mater Med. 2013 Dec;24(12):2809-17. doi: 10.1007/s10856-013-5012-4. Epub 2013 Jul 28. J Mater Sci Mater Med. 2013. PMID: 23892485
-
Physicochemical and Biological Characterisation of Diclofenac Oligomeric Poly(3-hydroxyoctanoate) Hybrids as β-TCP Ceramics Modifiers for Bone Tissue Regeneration.Int J Mol Sci. 2020 Dec 11;21(24):9452. doi: 10.3390/ijms21249452. Int J Mol Sci. 2020. PMID: 33322564 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources